Login

If you are a member of the general public and not a healthcare professional, NOVELTY study investigator or AstraZeneca Medical employee, please CLICK HERE to see information tailored to you.

News & events

Home > News & events

Here you can find news and features relating to the NOVELTY study as we embark on this journey of discovery.

Extra news for investigators and AstraZeneca Medical employees

Events

Read More

News

6th September, 2022

NOVELTY scientific congress presence in 2022

Read More

21st July, 2022

NOVELTY treatable traits manuscript published

Read More

19th June, 2022

NOVELTY frequent productive cough manuscript published

Read More

10th December, 2019

Severe obstructive lung disease review article published

We are pleased to announce that a review article entitled ‘Defining severe obstructive lung disease in the biologic era: an endotype-based approach’ has been published in the European Respiratory Journal.
Read More

7th April, 2016

A message from the NOVELTY Scientific Committee

We are very pleased to announce the launch of the NOVELTY study, and are enthusiastic to be working with physicians and study centres around the world to increase our knowledge of obstructive lung disease on a global, local and individual patient level.
Read More
19 PARTICIPATING COUNTRIESa
~12,000 ENROLLED PATIENTSa
84% OF PATIENTS HAVE SPIROMETRY DATAb

You are now leaving: http://aznoveltyproject.com/

By following this link you will be leaving the NOVELTY study website.

Please note that AstraZeneca does not take responsibility for the content displayed on other websites.

Continue Return to NOVELTY study